↓ Skip to main content

Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota

Overview of attention for article published in Frontiers in immunology, February 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
2 news outlets
blogs
2 blogs
twitter
87 X users

Citations

dimensions_citation
186 Dimensions

Readers on

mendeley
180 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota
Published in
Frontiers in immunology, February 2018
DOI 10.3389/fimmu.2018.00182
Pubmed ID
Authors

Helen T. Groves, Leah Cuthbertson, Phillip James, Miriam F. Moffatt, Michael J. Cox, John S. Tregoning

Abstract

Alterations in the composition of the gut microbiota have profound effects on human health. Consequently, there is great interest in identifying, characterizing, and understanding factors that initiate these changes. Despite their high prevalence, studies have only recently begun to investigate how viral lung infections have an impact on the gut microbiota. There is also considerable interest in whether the gut microbiota could be manipulated during vaccination to improve efficacy. In this highly controlled study, we aimed to establish the effect of viral lung infection on gut microbiota composition and the gut environment using mouse models of common respiratory pathogens respiratory syncytial virus (RSV) and influenza virus. This was then compared to the effect of live attenuated influenza virus (LAIV) vaccination. Both RSV and influenza virus infection resulted in significantly altered gut microbiota diversity, with an increase inBacteroidetesand a concomitant decrease inFirmicutesphyla abundance. Although the increase in theBacteroidetesphylum was consistent across several experiments, differences were observed at the family and operational taxonomic unit level. This suggests a change in gut conditions after viral lung infection that favorsBacteroidetesoutgrowth but not individual families. No change in gut microbiota composition was observed after LAIV vaccination, suggesting that the driver of gut microbiota change is specific to live viral infection. Viral lung infections also resulted in an increase in fecal lipocalin-2, suggesting low-grade gut inflammation, and colonic Muc5ac levels. Owing to the important role that mucus plays in the gut environment, this may explain the changes in microbiota composition observed. This study demonstrates that the gut microbiota and the gut environment are altered following viral lung infections and that these changes are not observed during vaccination. Whether increased mucin levels and gut inflammation drive, or are a result of, these changes is still to be determined.

X Demographics

X Demographics

The data shown below were collected from the profiles of 87 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 180 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 180 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 28 16%
Student > Ph. D. Student 27 15%
Student > Master 24 13%
Student > Doctoral Student 14 8%
Student > Bachelor 14 8%
Other 22 12%
Unknown 51 28%
Readers by discipline Count As %
Immunology and Microbiology 37 21%
Medicine and Dentistry 26 14%
Biochemistry, Genetics and Molecular Biology 26 14%
Agricultural and Biological Sciences 14 8%
Nursing and Health Professions 5 3%
Other 15 8%
Unknown 57 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 81. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 November 2021.
All research outputs
#535,000
of 25,766,791 outputs
Outputs from Frontiers in immunology
#492
of 32,353 outputs
Outputs of similar age
#13,073
of 457,016 outputs
Outputs of similar age from Frontiers in immunology
#3
of 664 outputs
Altmetric has tracked 25,766,791 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,353 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 457,016 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 664 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.